BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 11197777)

  • 1. [Transforming growth factor-beta signaling and cancer].
    Miyazono K
    Hum Cell; 2000 Sep; 13(3):97-101. PubMed ID: 11197777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crossing Smads.
    Wrana JL
    Sci STKE; 2000 Mar; 2000(23):re1. PubMed ID: 11752591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.
    Javelaud D; Mauviel A
    Oncogene; 2005 Aug; 24(37):5742-50. PubMed ID: 16123807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles.
    Javelaud D; Mauviel A
    Int J Biochem Cell Biol; 2004 Jul; 36(7):1161-5. PubMed ID: 15109563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
    Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
    Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
    Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB
    Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TGF-beta signaling and carcinogenesis].
    Kahata K; Asaka M; Miyazono K
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():549-54. PubMed ID: 15861709
    [No Abstract]   [Full Text] [Related]  

  • 8. Transforming growth factor beta signal transduction.
    Dennler S; Goumans MJ; ten Dijke P
    J Leukoc Biol; 2002 May; 71(5):731-40. PubMed ID: 11994497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta signaling in cancer.
    Rich J; Borton A; Wang X
    Microsc Res Tech; 2001 Feb; 52(4):363-73. PubMed ID: 11170295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [TGF-beta].
    Urano T; Ouchi Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():73-6. PubMed ID: 15035099
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of transforming growth factor-beta signaling.
    Zhu HJ; Burgess AW
    Mol Cell Biol Res Commun; 2001 Nov; 4(6):321-30. PubMed ID: 11703090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [TGF-beta family (TGF-beta, activin, BMP)].
    Koinuma D; Imamura T; Miyazono K
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():215-9. PubMed ID: 15861659
    [No Abstract]   [Full Text] [Related]  

  • 14. Receptor-regulated and inhibitory Smads are critical in regulating transforming growth factor beta-mediated Meckel's cartilage development.
    Ito Y; Bringas P; Mogharei A; Zhao J; Deng C; Chai Y
    Dev Dyn; 2002 May; 224(1):69-78. PubMed ID: 11984875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells.
    Rodeck U; Nishiyama T; Mauviel A
    Cancer Res; 1999 Feb; 59(3):547-50. PubMed ID: 9973198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Smad 7 and post-receptor signal regulation of transforming growth factor-beta1].
    Wu JX; Meng XJ; Chen YW; Cheng JL; Li DG; Lu HM
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):315-7. PubMed ID: 12773256
    [No Abstract]   [Full Text] [Related]  

  • 17. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
    Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
    Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergence and convergence of TGF-beta/BMP signaling.
    Miyazono K; Kusanagi K; Inoue H
    J Cell Physiol; 2001 Jun; 187(3):265-76. PubMed ID: 11319750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.
    Ferrand N; Atfi A; Prunier C
    Cancer Res; 2010 Nov; 70(21):8457-66. PubMed ID: 20959473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.